Chemokines in Cancer

被引:412
作者
Chow, Melvyn T. [1 ]
Luster, Andrew D. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Sch Med,Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA
关键词
REGULATORY T-CELLS; ENHANCES TUMOR PROGRESSION; BREAST-CANCER; IFN-GAMMA; ANTITUMOR-ACTIVITY; ADAPTIVE IMMUNITY; OVARIAN-CANCER; MYELOID CELLS; LYMPH-NODE; GROWTH;
D O I
10.1158/2326-6066.CIR-14-0160
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines are chemotactic cytokines that control the migration of cells between tissues and the positioning and interactions of cells within tissue. The chemokine superfamily consists of approximately 50 endogenous chemokine ligands and 20 G protein-coupled seven-transmembrane spanning signaling receptors. Chemokines mediate the host response to cancer by directing the trafficking of leukocytes into the tumor microenvironment. This migratory response is complex and consists of diverse leukocyte subsets with both antitumor and protumor activities. Although chemokines were initially appreciated as important mediators of immune cell migration, we now know that they also play important roles in the biology of nonimmune cells important for tumor growth and progression. Chemokines can directly modulate the growth of tumors by inducing the proliferation of cancer cells and preventing their apoptosis. They also direct tumor cell movement required for metastasis. Chemokines can also indirectly modulate tumor growth through their effects on tumor stromal cells and by inducing the release of growth and angiogenic factors from cells in the tumor microenvironment. In this Masters of Immunology primer, we focus on recent advances in understanding the complex nature of the chemokine system in tumor biology with a focus on how the chemokine system could be used to augment cancer immunotherapeutic strategies to elicit a more robust and long-lasting host antitumor immune response. (C) 2014 AACR.
引用
收藏
页码:1125 / 1131
页数:7
相关论文
共 77 条
[1]   A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis [J].
Acharyya, Swarnali ;
Oskarsson, Thordur ;
Vanharanta, Sakari ;
Malladi, Srinivas ;
Kim, Juliet ;
Morris, Patrick G. ;
Manova-Todorova, Katia ;
Leversha, Margaret ;
Hogg, Nancy ;
Seshan, Venkatraman E. ;
Norton, Larry ;
Brogi, Edi ;
Massague, Joan .
CELL, 2012, 150 (01) :165-178
[2]   The Inflammatory Chemokine CCL5 and Cancer Progression [J].
Aldinucci, Donatella ;
Colombatti, Alfonso .
MEDIATORS OF INFLAMMATION, 2014, 2014
[3]   IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer [J].
Andersson, Asa ;
Yang, Seok-Chul ;
Huang, Min ;
Zhu, Li ;
Kar, Upendra K. ;
Batra, Rai K. ;
Elashoff, David ;
Strieter, Robert M. ;
Dubinett, Steven M. ;
Sharma, Sherven .
JOURNAL OF IMMUNOLOGY, 2009, 182 (11) :6951-6958
[4]   Cancer and the chemokine network [J].
Balkwill, F .
NATURE REVIEWS CANCER, 2004, 4 (07) :540-550
[5]   Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes [J].
Bellone, Matteo ;
Calcinotto, Arianna .
FRONTIERS IN ONCOLOGY, 2013, 3
[6]   Tumorigenesis and the angiogenic switch [J].
Bergers, G ;
Benjamin, LE .
NATURE REVIEWS CANCER, 2003, 3 (06) :401-410
[7]   Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm [J].
Biswas, Subhra K. ;
Mantovani, Alberto .
NATURE IMMUNOLOGY, 2010, 11 (10) :889-896
[8]   The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor [J].
Bolitho, Christine ;
Hahn, Michael A. ;
Baxter, Robert C. ;
Marsh, Deborah J. .
ENDOCRINE-RELATED CANCER, 2010, 17 (04) :929-940
[9]   Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy [J].
Bos, Paula D. ;
Plitas, George ;
Rudra, Dipayan ;
Lee, Sue Y. ;
Rudensky, Alexander Y. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 210 (11) :2435-2446
[10]   CXCL10 Can Inhibit Endothelial Cell Proliferation Independently of CXCR3 [J].
Campanella, Gabriele S. V. ;
Colvin, Richard A. ;
Luster, Andrew D. .
PLOS ONE, 2010, 5 (09) :1-10